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Novel Recombinant
Norovirus in China
To the Editor: Norovirus (NoV),
the distinct genus within the family
Caliciviridae, is a major cause of spo-
radic cases and outbreaks of acute
gastroenteritis in humans (1). NoV
possesses a positive-sense, single-
stranded RNA genome surrounded by
an icosahedral capsid. The NoV
genome contains 3 open reading
frames (ORFs). ORF1 encodes non-
structural proteins, ORF 2 encodes
capsid protein (VP1), and ORF3
encodes a small capsid protein (VP2).
NoV is still uncultivable by standard
culture with different cell lines.
However, expression of either VP1 or
both VP1 and VP2 with recombinant
baculoviruses formed viruslike parti-
cles that are morphologically and
antigenically similar to the native viri-
on (2).
A fecal specimen was collected
from an infant hospitalized with acute
gastroenteritis in Kunming, China, in
November 2004 and was tested for
diarrheal viruses in a cooperative lab-
oratory in Japan. The viral genome
was extracted by using a Qiagen kit
(Qiagen, Hilden, Germany). Poly-
merase chain reaction with specific
primers resulted in the identification
of astrovirus, rotavirus, sapovirus,
adenovirus, and NoV genogroup I
(GI) and GII (3). NoV polymerase
was also amplified to identify recom-
binant NoV with primers Yuri22F and
Yuri22R (4). Products were
sequenced directly, and sequence
analysis was performed by using
ClustalX and SimPlot.
The fecal specimen was positive
for NoV GII. The Figure shows that
the 146/Kunming/04/China sequence
clustered into the distinct GII geno-
type 7 (Leeds/90/UK cluster).
146/Kunming/04/China was classi-
fied into the Saitama U4 cluster (GI/6)
when polymerase-based grouping was
performed. Altogether, 146/Kunming/
04/China was expected to be the
recombinant NoV with GII/7 capsid
and GII/6 polymerase.
To eliminate the possibility of co-
infection with 2 different NoV geno-
types, to localize the potential recom-
bination site, and to clarify a possible
recombination mechanism, the
ORF1/ORF2 overlap and flanking
polymerase and capsid regions of
146/Kunming/04/China was ampli-
fied with primers Yuri22F and
GIISKR to produce a 1,158-bp ampli-
con (3,4). When the sequence of
146/Kunming/04/China was com-
pared with that of Saitama U4 by
using SimPlot, a recombination site
was found at the ORF1/ORF2 over-
lap. Before this junction, 146/
Kunming/04/China and Saitama U4
were homologous. After the
ORF1/ORF2 overlap, however, the
homology was notably different.
SimPlot showed a sudden drop in the
nucleotide identity for 146/Kunming/
04/China. ClustalX showed that
146/Kunming/04/China shared a high
identity (93%) in the polymerase
region and a low identity (78%) in the
capsid region with Saitama U4. In
contrast, high identity (95%) in the
capsid region was found between
146/Kunming/04/China and Leeds/
90/UK. Since Leeds/90/UK poly-
merase was not available in GenBank,
the polymerase homology between
146/Kunming/04/China and Leeds/
90/UK was unknown. Polymerase of
146/Kunming/04/China was almost
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Figure. Changes in norovirus (NoV) genotypes on the basis of phylogentic trees of
nucleotide sequences of 146/Kunming/04/China. Trees were constructed from partial
nucleotide sequences of capsid and polymerase regions of 146/Kunming/04/China.
146/Kunming/04/China is boldface. Dashed boxes indicate the maintenance of geno-
types of reference NoV strains, and solid boxes indicate the involvement of NoV geno-
types with recombinant NoV 146/Kunming/04/China. A phylogenetic tree with 100 boot-
strap resamples of the nucleotide alignment datasets was generated by using the neigh-
bor-joining method with ClustalX. The genetic distance was calculated by using the
Kimura 2-parameter method (PHYLIP). The scale indicates nucleotide substitutions per
position. The numbers in the branches indicate the bootstrap values. Manchester strain
was used as an outgroup strain for phylogenetic analysis. The nucleotide sequence of
NoV strain 146/Kunming/04/China had been submitted to GenBank and has been
assigned accession no. DQ304651. Reference NoV strains and accession nos. used in
this study are as follows: Manchester (X86560), Toronto (U02030), Melksham (X81879),
Camberwell (AF145896), Leeds/90/UK (AJ277608), Lordsdale (X86557), Hawaii
(U07611), Saitama U3 (AB039776), Saitama U4 (AB039777), and Miami/94/US
(AF414410).LETTERS
identical with that of Saitama U4, but
the capsids of 146/Kunming/04/China
and Leeds/90/UK were distinctly dif-
ferent from that of Saitama U4. This
genetic pattern of 146/Kunming/
04/China implied a novel, naturally
occurring recombinant NoV with
GII/7 capsid and GII/6 polymerase.
RNA recombination is a mecha-
nism for virus evolution (5). Literature
documenting recombination in NoV is
fairly rich, but none is from China (6).
Therefore, 146/ Kunming/04/China
was not only the first but also the first
recombinant NoV from China. This
isolate shared the closest sequences of
polymerase and capsid with Saitama
U4 and Leeds/90/UK, respectively.
Strain Saitama U4 was detected in
1997 in Japan (7), whereas strain
Leeds/90/ UK was detected in 1990 in
the United Kingdom (8). Quite possi-
bly, Saitama U4 and Leeds/90/UK
were parental strains of 146/Kunming/
04/China. However, the distant geo-
graphic relationship of these strains
obscured evidence of where and when
the recombination event occurred.
This phenomenon also suggested that
these parent strains or this progeny
strain might be more prevalent than is
often assumed.
Recombination depends on vari-
ous immunologic and intracellular
constraints. Recombinant viruses are
all alike in that they successfully pass
through 5 stages: 1) successful co-
infection of a single host, 2) success-
ful co-infection of a single cell,
3) efficient replication of both
parental strains, 4) template switch-
ing, and 5) purifying selection (9). In
this study, 146/Kunming/04/China
was recovered from a patient with
diarrhea, fever, and vomiting. This
observation indicated that this strain
theoretically fulfilled all prerequisites
for recombination.
The NoV capsid is predicted to be
well suited for genotype classification
(10). In this study, 146/Kunming/
04/China belonged to 2 distinct geno-
types, 7 and 6, by capsid- and poly-
merase-based groupings, respectively.
Moreover, the recent demonstration
of recombination in an increasing
number of NoVs suggests that it is a
more widespread event than was pre-
viously realized. Consequently, the
phylogenetic classification of NoV on
the basis of on capsid sequence is
questionable. We suggest that classifi-
cation of NoV strains should rely on
not only capsid sequence but also
polymerase sequence.
In conclusion, our results de-
scribed the genetic characterization of
novel, naturally occurring recombi-
nant NoV and increased evidence for
the worldwide distribution of recom-
binant NoV. This report is the first to
describe acute gastroenteritis caused
by recombinant NoV in China and
warns of the threat it poses.
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